These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8763815)

  • 1. Autoimmune T cells in myasthenia gravis: heterogeneity and potential for specific immunotargeting.
    Hawke S; Matsuo H; Nicolle M; Malcherek G; Melms A; Willcox N
    Immunol Today; 1996 Jul; 17(7):307-11. PubMed ID: 8763815
    [No Abstract]   [Full Text] [Related]  

  • 2. Possible strategies for the treatment of myasthenia gravis and other autoimmune diseases.
    Nossal GJ
    Ann N Y Acad Sci; 1987; 505():610-8. PubMed ID: 3500669
    [No Abstract]   [Full Text] [Related]  

  • 3. Prospects for specific immunotherapy in myasthenia gravis.
    Steinman L; Mantegazza R
    FASEB J; 1990 Jul; 4(10):2726-31. PubMed ID: 2197152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current and future therapies for myasthenia gravis.
    Yi Q; Lefvert AK
    Drugs Aging; 1997 Aug; 11(2):132-9. PubMed ID: 9259176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity and immunotherapy of specific T-cells in myasthenia gravis.
    Bond A; Corlett L; Nagvekar N; Jacobson L; Pantic N; Beeson D; Nicolle M; Vincent A; Newsom-Davis J; Spack E; Willcox N
    Biochem Soc Trans; 1997 May; 25(2):665-70. PubMed ID: 9191178
    [No Abstract]   [Full Text] [Related]  

  • 6. Does the thymus play opposite roles in SLE and myasthenia gravis?
    Díaz-Jouanen E; de la Fuente JR; Llorente L; Rivero SJ; Alarcón-Segovia D
    Arthritis Rheum; 1978 May; 21(4):492-3. PubMed ID: 306825
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical and biological heterogeneity of autoimmune myasthenia gravis.
    Pal J; Rozsa C; Komoly S; Illes Z
    J Neuroimmunol; 2011 Feb; 231(1-2):43-54. PubMed ID: 21093931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphocyte activation in experimental autoimmune myasthenia gravis.
    De Baets MH; Einarson B; Lindstrom JM; Weigle WO
    J Immunol; 1982 May; 128(5):2228-35. PubMed ID: 6977589
    [No Abstract]   [Full Text] [Related]  

  • 9. New experimental autoimmune models.
    Mozes E; Brocke S; Fricke H; Dayan M; Shoenfeld Y; Mendlovic S
    Isr J Med Sci; 1989 Dec; 25(12):692-5. PubMed ID: 2693401
    [No Abstract]   [Full Text] [Related]  

  • 10. Myasthenia gravis. Its pathophysiology, diagnosis, and treatment.
    Lin JT; Singer PA
    J Kans Med Soc; 1983 Feb; 84(2):53-8, 60. PubMed ID: 6833821
    [No Abstract]   [Full Text] [Related]  

  • 11. The third Euromyasthenia Conference; meeting report and update on myasthenia research.
    Willcox N
    Autoimmunity; 1992; 11(3):209-12. PubMed ID: 1373962
    [No Abstract]   [Full Text] [Related]  

  • 12. Specificity of the T cell immune response to acetylcholine receptor in experimental autoimmune myasthenia gravis. Response to subunits and synthetic peptides.
    Fujii Y; Lindstrom J
    J Immunol; 1988 Mar; 140(6):1830-7. PubMed ID: 2450133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myasthenia gravis: immunological mechanisms and immunotherapy.
    Lewis RA; Selwa JF; Lisak RP
    Ann Neurol; 1995 May; 37 Suppl 1():S51-62. PubMed ID: 8968217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmune T cell recognition of human acetylcholine receptor: the sites of T cell recognition in myasthenia gravis on the extracellular part of the alpha subunit.
    Oshima M; Ashizawa T; Pollack MS; Atassi MZ
    Eur J Immunol; 1990 Dec; 20(12):2563-9. PubMed ID: 2269324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies for treatment of myasthenia gravis.
    Drachman DB; McIntosh KR; Reim J; Balcer L
    Ann N Y Acad Sci; 1993 Jun; 681():515-28. PubMed ID: 8357193
    [No Abstract]   [Full Text] [Related]  

  • 16. [Thymectomy in myasthenia gravis].
    Eckmann L
    Schweiz Med Wochenschr; 1974 Jan; 104(3):74-7. PubMed ID: 4543947
    [No Abstract]   [Full Text] [Related]  

  • 17. [Myasthenia gravis. Prototype of an anti-receptor autoaggression disease (author's transl)].
    Hohlfeld R; Wekerle H
    MMW Munch Med Wochenschr; 1981 Jul; 123(31):1207-11. PubMed ID: 6790965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoimmune recognition profile of the alpha chain of human acetylcholine receptor in myasthenia gravis.
    Ashizawa T; Oshima M; Ruan KH; Atassi MZ
    Adv Exp Med Biol; 1991; 303():255-61. PubMed ID: 1805569
    [No Abstract]   [Full Text] [Related]  

  • 19. The limitation of IL-10-exposed dendritic cells in the treatment of experimental autoimmune myasthenia gravis and myasthenia gravis.
    Xiao BG; Duan RS; Zhu WH; Lu CZ
    Cell Immunol; 2006 Jun; 241(2):95-101. PubMed ID: 17005165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the nature of autoimmunity in myasthenia gravis. Evidence for an immunodeficiency type.
    Simpson JA; Behan PO; Dick HM
    Ann N Y Acad Sci; 1976; 274():382-9. PubMed ID: 134659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.